Current and historical daily PE Ratio for WuXi Biologics (Cayman) Inc (
) from 2017 to May 13 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. WuXi Biologics (Cayman) stock (FRA:1FW2) PE ratio as of May 13 2024 is 17.41.
More Details
WuXi Biologics (Cayman) Inc (FRA:1FW2) PE Ratio (TTM) Chart
WuXi Biologics (Cayman) Inc (FRA:1FW2) PE Ratio (TTM) Historical Data
View and export this data going back to 2017. Start your Free Trial
Total 1236
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| WuXi Biologics (Cayman) PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-14 | 18.3 | 2024-03-06 | 22.1 |
| 2024-05-10 | 18.3 | 2024-03-05 | 23.4 |
| 2024-05-09 | 17.6 | 2024-03-04 | 24.6 |
| 2024-05-08 | 17.1 | 2024-03-01 | 22.2 |
| 2024-05-07 | 17.2 | 2024-02-29 | 22.4 |
| 2024-05-06 | 17.9 | 2024-02-28 | 21.9 |
| 2024-05-03 | 16.9 | 2024-02-27 | 22.1 |
| 2024-05-02 | 17.7 | 2024-02-26 | 22.3 |
| 2024-04-30 | 16.7 | 2024-02-23 | 21.9 |
| 2024-04-29 | 16.9 | 2024-02-22 | 21.5 |
| 2024-04-26 | 16.6 | 2024-02-21 | 21.8 |
| 2024-04-25 | 15.2 | 2024-02-20 | 20.2 |
| 2024-04-24 | 15.3 | 2024-02-19 | 19.6 |
| 2024-04-23 | 15.6 | 2024-02-16 | 20.9 |
| 2024-04-22 | 15.3 | 2024-02-15 | 18.7 |
| 2024-04-19 | 15.2 | 2024-02-14 | 19.3 |
| 2024-04-18 | 16.1 | 2024-02-13 | 21.0 |
| 2024-04-17 | 16.2 | 2024-02-12 | 21.1 |
| 2024-04-16 | 15.9 | 2024-02-09 | 21.1 |
| 2024-04-15 | 16.2 | 2024-02-08 | 21.8 |
| 2024-04-12 | 16.6 | 2024-02-07 | 23.0 |
| 2024-04-11 | 16.6 | 2024-02-06 | 22.4 |
| 2024-04-10 | 17.3 | 2024-02-05 | 20.9 |
| 2024-04-09 | 17.2 | 2024-02-02 | 20.1 |
| 2024-04-08 | 17.0 | 2024-02-01 | 24.8 |
| 2024-04-05 | 15.4 | 2024-01-31 | 24.3 |
| 2024-04-04 | 17.3 | 2024-01-30 | 26.4 |
| 2024-04-03 | 16.9 | 2024-01-29 | 28.2 |
| 2024-04-02 | 17.2 | 2024-01-26 | 29.9 |
| 2024-03-28 | 16.8 | 2024-01-25 | 36.3 |
| 2024-03-27 | 16.4 | 2024-01-24 | 33.5 |
| 2024-03-26 | 16.0 | 2024-01-23 | 34.5 |
| 2024-03-25 | 16.6 | 2024-01-22 | 31.8 |
| 2024-03-22 | 15.8 | 2024-01-19 | 33.0 |
| 2024-03-21 | 17.0 | 2024-01-18 | 33.9 |
| 2024-03-20 | 16.7 | 2024-01-17 | 33.3 |
| 2024-03-19 | 16.7 | 2024-01-16 | 35.8 |
| 2024-03-18 | 17.1 | 2024-01-12 | 35.0 |
| 2024-03-15 | 17.3 | 2024-01-11 | 35.3 |
| 2024-03-14 | 18.8 | 2024-01-10 | 33.9 |
| 2024-03-13 | 22.0 | 2024-01-09 | 30.9 |
| 2024-03-12 | 22.3 | 2024-01-08 | 31.4 |
| 2024-03-11 | 21.3 | 2024-01-05 | 32.0 |
| 2024-03-08 | 20.5 | 2024-01-04 | 32.9 |
| 2024-03-07 | 20.2 | 2024-01-03 | 33.1 |
WuXi Biologics (Cayman) Inc (FRA:1FW2) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
WuXi Biologics (Cayman) Inc
ISIN : KYG970081090
Share Class Description:
FRA:1FW2: Registered Shs Unitary 144A/Reg SCompare
Compare
Traded in other countries / regions
02269.Hong KongWXXWY.USA1FW2.Germany2269.Mexico IPO Date
2017-06-15Description
WuXi Biologics is one of the largest global biologics CRDMOs. WuXi Biologics, incorporated in 2014 following the reorganization of WuXi PharmaTech, later known as WuXi AppTec, now has global revenue of CNY 17 billion. North America represented 47.4% of total revenue in 2023. It adopts the follow and win the molecule strategy by providing end-to-end services, from drug discovery to commercial manufacturing. It also adopts a global dual-sourcing strategy by providing drug products and large-scale drug substance manufacturing.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers